WCM Investment Management LLC increased its position in Molina Healthcare, Inc (NYSE:MOH – Free Report) by 11.4% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 1,868 shares of the company’s stock after purchasing an additional 191 shares during the period. WCM Investment Management LLC’s holdings in Molina Healthcare were worth $555,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Zions Bancorporation National Association UT purchased a new stake in Molina Healthcare during the 1st quarter valued at approximately $29,000. Deseret Mutual Benefit Administrators raised its stake in Molina Healthcare by 60.7% during the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company’s stock valued at $30,000 after acquiring an additional 34 shares during the last quarter. Elequin Capital LP raised its stake in Molina Healthcare by 170.6% during the 1st quarter. Elequin Capital LP now owns 92 shares of the company’s stock valued at $30,000 after acquiring an additional 58 shares during the last quarter. Silver Oak Securities Incorporated purchased a new stake in Molina Healthcare during the 1st quarter valued at approximately $34,000. Finally, Allworth Financial LP raised its stake in Molina Healthcare by 52.0% during the 1st quarter. Allworth Financial LP now owns 228 shares of the company’s stock valued at $72,000 after acquiring an additional 78 shares during the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research firms have commented on MOH. Wells Fargo & Company upped their price objective on Molina Healthcare from $198.00 to $231.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $210.00 price objective on shares of Molina Healthcare in a research note on Tuesday, August 26th. Sanford C. Bernstein reduced their price objective on Molina Healthcare from $284.00 to $220.00 and set an “outperform” rating for the company in a research note on Friday, September 5th. Robert W. Baird reduced their price objective on Molina Healthcare from $373.00 to $179.00 and set a “neutral” rating for the company in a research note on Friday, July 25th. Finally, UBS Group reduced their price objective on Molina Healthcare from $260.00 to $180.00 and set a “neutral” rating for the company in a research note on Friday, July 25th. Three research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $222.15.
Molina Healthcare Stock Performance
NYSE MOH opened at $188.26 on Friday. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.77. The business’s 50 day moving average is $181.22 and its two-hundred day moving average is $245.68. Molina Healthcare, Inc has a 12-month low of $151.95 and a 12-month high of $359.97. The stock has a market capitalization of $10.20 billion, a price-to-earnings ratio of 9.28 and a beta of 0.55.
Molina Healthcare (NYSE:MOH – Get Free Report) last released its earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The business had revenue of $11.43 billion for the quarter, compared to analyst estimates of $10.94 billion. During the same quarter in the previous year, the firm posted $5.86 EPS. The business’s revenue for the quarter was up 15.7% on a year-over-year basis. Research analysts expect that Molina Healthcare, Inc will post 24.4 EPS for the current year.
Insider Activity at Molina Healthcare
In related news, Director Ronna Romney sold 700 shares of the company’s stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total value of $107,618.00. Following the sale, the director owned 17,131 shares in the company, valued at $2,633,719.94. This represents a 3.93% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO James Woys purchased 10,000 shares of the stock in a transaction that occurred on Monday, August 4th. The stock was purchased at an average price of $155.94 per share, for a total transaction of $1,559,400.00. Following the acquisition, the chief operating officer owned 74,331 shares in the company, valued at approximately $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.10% of the company’s stock.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Further Reading
- Five stocks we like better than Molina Healthcare
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Salesforce’s Long-Awaited Inflection is Here: Rally On!
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Rocket Lab USA Receives Wall Street Validation: Time to Buy?
- Investing in Commodities: What Are They? How to Invest in Them
- Archer Buys Rival’s Patent Treasure Trove in Strategic Move
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.